Page 4 - தகுதி நிறுவன வாங்குபவர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Windlas Biotech raises over Rs 120 crore from anchor investors ahead of IPO The company has decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according to a circular uploaded on BSE website The Initial Public Offer (IPO) comprises fresh issuance of equity shares worth Rs 165 crore (Source: PTI) PTI Updated Aug 04, 2021, 1:18 PM IST Windlas Biotech, a manufacturer of pharmaceutical formulations, on Tuesday said it has raised over Rs 120 crore from anchor investors ahead of its IPO that opens on Wednesday. The company has decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according to a circular uploaded on BSE website.

Dixitkumar patelTano india private equity fundCommerce life insurance companyElara india opportunities fundPrudential mutual fundCapital markets ltdKuber india fundWindlas biotechMutual fundCommerce life insuranceInitial public offerVimla windlassQualified institutional buyersRunning lead managersMarkets ltdExxaro tiles